phentolamine ophthalmic (Pending FDA Approval)

Brand and Other Names:Nyxol
Sections

Dosing & Uses

Mydriasis Reversal

Pending FDA approval for reversal of pharmacologically-induced mydriasis produced by adrenergic agonist (eg, phenylephrine) or parasympatholytic (eg, tropicamide) agents, a combination of both

Next:

Pharmacology

Mechanism of Action

Nonselective alpha adrenergic antagonist that inhibits the contraction of smooth muscle of the iris

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.